Fortnightly Review: Vascular dementia

BMJ 1996;312:227-231 (27 January)

Education and debate

Fortnightly Review: Vascular dementia

Khaled Amar, lecturer in care for the elderly,^a Gordon Wilcock, professor in care for the elderly ^a

^a Bristol University, Department of Care of the Elderly, Frenchay Hospital, Bristol BS16 1LE

Correspondence to: Professor Wilcock.

Summary points

Symptomatic stroke increases the risk of dementia more than ninefold
Vascular dementia is one of the three commonest causes of dementia
Above the age of 85 years it may be commoner than Alzheimer's disease
Vascular dementia may be caused by multiple infarcts, white matter ischaemia, or a strategically placed infarct
All patients with possible vascular dementia need careful assessment to detect any underlying causes and risk factors that might be remediable

Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to StumbleUpon StumbleUpon Add to Technorati Technorati What's this?

This article has been cited by other articles:

Hua Liu, , Ming Liu, , Wei Li, , Bo Wu, , Zhang, S.-h., Yuan Fang, , Yi Wang, (2009). Association of ACE I/D Gene Polymorphism With Vascular Dementia: A Meta-Analysis. J Geriatr Psychiatry Neurol 22: 10-22 [Abstract]
Wiederkehr, S., Simard, M., Fortin, C., van Reekum, R. (2008). Comparability of the Clinical Diagnostic Criteria for Vascular Dementia: A Critical Review. Part I. J. Neuropsychiatry Clin. Neurosi. 20: 150-161 [Abstract] [Full text]
Kemeny, V., Molnar, S., Andrejkovics, M., Makai, A., Csiba, L. (2005). Acute and Chronic Effects of Vinpocetine on Cerebral Hemodynamics and Neuropsychological Performance in Multi-infarct Patients. J Clin Pharmacol 45: 1048-1054 [Abstract] [Full text]
Etminan, M., Gill, S., Samii, A. (2003). Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ 327: 128- [Abstract] [Full text]
Orgogozo, J.-M., Rigaud, A.-S., Stoffler, A., Mobius, H.-J., Forette, F. (2002). Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia: A Randomized, Placebo-Controlled Trial (MMM 300). Stroke 33: 1834-1839 [Abstract] [Full text]
Blauw, G.J., Bollen, E.L.E.M., van Buchem, M.A., Westendorp, R.G.J. (2001). Dementia at old age: a clinical end-point of atherosclerotic disease. Eur Heart J Suppl 3: N16-N19 [Abstract]
Chapman, J., Wang, N., Treves, T. A., Korczyn, A. D., Bornstein, N. M. (1998). ACE, MTHFR, Factor V Leiden, and APOE Polymorphisms in Patients With Vascular and Alzheimer's Dementia. Stroke 29: 1401-1404 [Abstract] [Full text]
Ott, A., Breteler, M. M.B., de Bruyne, M. C., van Harskamp, F., Grobbee, D. E., Hofman, A. (1997). Atrial Fibrillation and Dementia in a Population-Based Study: The Rotterdam Study. Stroke 28: 316-321 [Abstract] [Full text]